挑战人类基因组编辑治疗,预防和改进之间的界限
Margaret Waltz1, Rebecca L Walker1,2, Michael A Flatt3
1Department of Social Medicine and Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
The CRISPR journal
|July 8, 2024
概括
人类基因组编辑 (HGE) 治理面临的挑战是区分治疗,预防和增强目标. 科学家 科学家 科学家
科学领域:
- 遗传学和生物伦理学
- 人类基因组编辑治理治理
背景情况:
- 人类基因组编辑 (HGE) 的治疗和增强目标之间的传统区别影响了监督.
- 将预防作为HGE目标的增加使这些既定类别变得复杂.
研究的目的:
- 评估治疗,预防和增强类别在正在进行的HGE治理中的作用.
- 了解科学家和治理专家如何看待这些区别.
主要方法:
- 与基因组编辑科学家进行的定性采访.
- 采访HGE治理小组成员.
主要成果:
- 一些参与者在治疗和增强之间保持了严格的区别,拒绝增强.
- 其他人认为增强的概念无关紧要或在道德上不那么关心.
- 预防性HGE目标创造了"灰色地带",模糊了预防和增强之间的界限,可能会阻碍HGE应用.
结论:
- 对治疗,预防和增强的不同理解影响了HGE治理.
- 导航这些区别是至关重要的,因为HGE研究扩展到疾病治疗之外的长期预防.
相关概念视频
What is Genetic Engineering?
74.0K
Overview
74.0K
CRISPR
50.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.4K
Homologous Recombination
50.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.4K
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K


